GAVI alliance offers matched funds for GSK malaria vaccine pilot
June 23, 2016 at 10:57 AM EDT
LONDON, June 23 (Reuters) - The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organisations promise to match that commitment.